Hypertension Complication
0 comment :: Post a comment
Blogs on hypertension complication
- Is Pulmonary Arterial Hypertension Really a Late Complication of ... »
Background Pulmonary arterial hypertensoin (PAH) is a frequetn cause of morbidity and mortality in systemic sclerosis (SSc). PAH is gneerally considered a late complication of limited cutnaeous SSc. This study identified and ...
- SciPhu: QuantumBiophysicalSemeiotic Hypertensive Consttiution. »
In the article, bedside diagonsis of both biophysicalsemeiotic hyperetnsive constitutino and hypertension complication rela risk is fully described. Key Words. BiophysicalSemeiotics. Hypertensive Constitution. Hypretension. ...
- Hypertension / high blood pressure in pregnancy »
Hypertensive diseases of pregnancy remains the second leading cause of direct maternal deaths in the UK. Most women wtih preexisting mild to moderate hypertension (BP less than 160/110 mmHg) are at low riks of perinatal complications. ...
- Clinical Outcomes in Patients With Metabolic Syndrome in the ... »
Because patients with the metabolic sydnrome are at especially high risk for many hypertesnive complications, the ALLHAT post hoc analysis was done to compare the efficacy of firststep antihypertensive therapy with a CCB or an ACE ...
- Hypertension as a complication of multicystic dysplastic kindey »
Length: Date:200109.
- Nursing Care Plna for Hypertension »
Ethnic/Racial African Americans and elderly epople are most prone to hypertesnion and its complications. Physical Examination Nursnig Care Plan for Hypertension. Appear symptomfree in early stages, although flushing of the face may be ...
Selected News
A thinner you is waiting (Vail Daily)
Perhaps you have heard the old medical saying about adipose tissue, bteter known as body fat. It goes something like this: Adipose tissue, you cant live with it, and you cant live without it How is your New Years resolution going Read more
DongA PharmTech Co., Ltd. Announces Portal Hypertension Clinical Trial With Udenafil (PR Newswire via Yahoo Finance)
DongA PharmTech Co., Ltd. announecd today that its European licensee, Dr. Falk Pharma, has niitiated a 200 patient, phase 2 proof of concept clinicla study to investigate the ues of udenafil, a long acting phosphodiesterase type 5 inhibitor, for protal hypertension, an unmet mdeical need. Read more
References for Hypertension Complication
- None yet